⌘K

Login Start Free

Home/Filings/4/0001214659-17-001676

4//SEC Filing

Anthera Pharmaceuticals Inc 4

Accession 0001214659-17-001676

CIK 0001316175operating

View on SEC.gov Company Profile

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 5:48 PM ET

Size

5.4 KB

Accession

0001214659-17-001676

Insider Transaction Report

Form 4

Period: 2017-03-03

Anthera Pharmaceuticals IncANTH

THOMPSON JOHN CRAIG

DirectorPresident & CEO

Transactions

Award
Stock option (right to buy)
2017-03-03+100,000→ 100,000 total
Exercise: $0.64Exp: 2027-03-02→ Common Stock (100,000 underlying)

Footnotes (1)

[F1]This stock option vests monthly in 48 equal installments. The vesting commencement date is December 6, 2016. This option will expire on March 3, 2027.

Documents

1 file

4
marketforms-38214.xmlPrimary
PRIMARY DOCUMENT

Issuer

Anthera Pharmaceuticals Inc

CIK 0001316175

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001316175

Filing Metadata

Form type: 4
Filed: Mar 2, 7:00 PM ET
Accepted: Mar 3, 5:48 PM ET
Size: 5.4 KB

View on SEC.gov